UBS lowered the firm’s price target on Houlihan Lokey (HLI) to $160 from $163 and keeps a Neutral rating on the shares.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HLI:
- Analyst Maintains Buy on Houlihan Lokey, Viewing Earnings Miss as Temporary Amid Strengthening Multi‑Year Growth Outlook
- Houlihan Lokey reports Q4 adjusted EPS $1.63, consensus $1.79
- Houlihan Lokey Inc. (HLI) Q4 Earnings Cheat Sheet
- Houlihan Lokey price target lowered to $193 from $205 at Morgan Stanley
- Houlihan Lokey price target lowered to $177 from $214 at Keefe Bruyette